Public consultation on ICH Guideline Q5A(R2) “Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin” launched in Switzerland
2. Dezember 2022
Swissmedic launches the public consultation on Guideline Q5A(R2) of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH Guidelines), with a deadline of 10 February 2023 for comments.
For more information, see here.